thiazolyl blue has been researched along with B-Cell Lymphoma in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Allen, TM; Ma, J; Moase, EH; Sapra, P | 1 |
1 other study(ies) available for thiazolyl blue and B-Cell Lymphoma
Article | Year |
---|---|
Improved therapeutic responses in a xenograft model of human B lymphoma (Namalwa) for liposomal vincristine versus liposomal doxorubicin targeted via anti-CD19 IgG2a or Fab' fragments.
Topics: Animals; Antibiotics, Antineoplastic; Antibodies, Monoclonal; Antigens, CD19; Antineoplastic Agents, Phytogenic; Cell Line, Tumor; Disease Models, Animal; Dose-Response Relationship, Drug; Doxorubicin; Female; Humans; Immunoglobulin Fragments; Immunoglobulin G; Inhibitory Concentration 50; Liposomes; Lymphoma, B-Cell; Mice; Mice, Inbred BALB C; Mice, SCID; Neoplasm Transplantation; Tetrazolium Salts; Thiazoles; Time Factors; Vincristine | 2004 |